Clinical Trials - Phase I
Filter News
Found 21,051 articles
-
BerGenBio AS Announces Initiation of Phase I Clinical Trial for First-in-Class AXL Receptor Tyrosine Kinase Inhibitor BGB324 to Treat Aggressive and Metastatic Cancers
6/20/2013
-
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)
6/20/2013
-
Allied's Herpes Vaccine Progresses to Phase 1 Clinical Trial
6/19/2013
-
Vaxart, Inc.’s Groundbreaking Tablet Influenza Vaccine Generates Protective Antibody Levels in Humans
6/19/2013
-
Senesco Technologies, Inc. Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial
6/19/2013
-
University of California, Los Angeles (UCLA) Presents Data on MediciNova, Inc.'s MN-166 in Methamphetamine Addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence
6/19/2013
-
PhaseBio Pharmaceuticals, Inc. Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases
6/18/2013
-
DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus
6/18/2013
-
Vaxil Reports Promising Results From Its Follow-Up Clinical Trial of ImMucin in Multiple Myeloma a Patients
6/18/2013
-
Versartis, Inc. Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at ENDO Annual Meeting
6/17/2013
-
Cell Therapeutics, Inc. Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients With Myelofibrosis
6/17/2013
-
AbbVie Presents Preliminary Results From Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6/17/2013
-
Array BioPharma, Inc. Announces Positive Interim Results From Combination Trial of ARRY-520 With Kyprolis at the 2013 European Hematology Association Congress
6/17/2013
-
Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215 for the Treatment of Multiple Myeloma
6/17/2013
-
NPS Pharmaceuticals, Inc. Release: Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients With Hypoparathyroidism
6/17/2013
-
Nanobiotix Receives Approval From ANSM to Start New Clinical Trial With Lead Product NBTXR3
6/13/2013
-
Omeros Corporation Obtains Regulatory Approval to Initiate Phase 1 Clinical Trial for Lead Antibody in MASP-2 Program
6/13/2013
-
Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
6/13/2013
-
Verastem, Inc. Receives Orphan Drug Designation in the EU for VS-6063 in Mesothelioma
6/13/2013
-
NW Bio Has Initiated Its DCVax®-Direct Phase I/II Trial for All Solid Tumor Cancers
6/13/2013